Global Assisted Reproductive Technology Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2021-2027. Assisted Reproductive Technology (ART) is used to treat infertility. In vitro fertilization (IVF) is the effective and most common form of ART. Whereas, multiple pregnancy related issues is the most common problem associated with ART. The market is driven by the key factors such as Rise in Number of Single Women and Same-sex Couples and increasing number of Infertility Cases. According to the World Health Organization (WHO), 186 million people and 48 million couples were diagnosed with infertility by 2020. According to the Centers for Disease Control and Prevention (CDC), around 6 percent to 12 percent of PCOS-affected women in the United States also have infertility issues. As a result, the infertility rate rises with the rise in prevalence of PCOS, fueling the demand for assisted reproductive technologies. One of the contributing factors to market growth is technological advancements. For instance, VitriCell SA announced the achievement of a USD 1.2 million investment in January 2018. These funds are intended to help the company to launch aseptic vitrification-based goods (new cell cryopreservation technique). In the next years, this is likely to have a beneficial influence on the ART market. However, Changing Government Regulations, may impede market growth over the forecast period of 2021-2027.
Complete Report Details @ https://www.intelligencemarketreport.com/market-report/assisted-reproductive-technology-art-market
Geographically, Europe is the leading region and holding the major share of market due to the increase in utilization of novel technology equipment services, high disposable income and rise in incidence of infertility cases. However, Asia pacific is the fastest growing region factors are rise in awareness about surrogacy and increase in demand for assisted reproductive technology.
Major market player included in this report are:
FUJIFILM Irvine Scientific, Inc.
Bloom IVF Centre
Nidacon International AB
Hamilton Thorne Inc.
OvaScience Inc.
CooperSurgical Inc
Laboratoire CCD
Ferring B.V.
Vitrolife
Microm Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
In Vitro-fertilization (IVF)
Artificial Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By End user:
Hospital
Fertility Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Request for Sample report with detailed industry analysis @ https://www.intelligencemarketreport.com/report-sample/146622
Contact Us:
Intelligence Market Report
Sales@intelligencemarketreport.com
Ph no: +44 20 8144 2758 (UK)
